CIPLA VALGANCICLOVIR valganciclovir (as hydrochloride) 450 mg tablet bottle

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

valganciclovir hydrochloride, Quantity: 496.3 mg (Equivalent: valganciclovir, Qty 450 mg)

Boleh didapati daripada:

Cipla Australia Pty Ltd

INN (Nama Antarabangsa):

Valganciclovir hydrochloride

Borang farmaseutikal:

Tablet, film coated

Komposisi:

Excipient Ingredients: povidone; stearic acid; crospovidone; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 6000; iron oxide red

Laluan pentadbiran:

Oral

Unit dalam pakej:

60 tablets

Jenis preskripsi:

(S4) Prescription Only Medicine

Tanda-tanda terapeutik:

CIPLA VALGANCICLOVIR is indicated for the treatment of cytomegalovirus (CMV) retinitis in adult patients with acquired immunodeficiency syndrome (AIDS).,CIPLA VALGANCICLOVIR is indicated for the prophylaxis of CMV disease in adult and paediatric solid organ transplantation (SOT) patients who are at risk.

Ringkasan produk:

Visual Identification: Pink coloured, capsule shaped, biconvex film coated tablet plain on both sides; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Status kebenaran:

Licence status A

Tarikh kebenaran:

2016-09-02